Cooper Companies (COO) Non-Current Deferred Tax Liability (2009 - 2026)
Cooper Companies (COO) posted Non-Current Deferred Tax Liability of $96.4 million for Q2 2026, little changed on a QoQ basis from $96.3 million in Q1 2026, and down 2.72% year-over-year from $99.1 million in Q2 2025.
Analysis
Cooper Companies (COO) Non-Current Deferred Tax Liability (2009 - 2026) Analysis & Trends
Cooper Companies has reported Non-Current Deferred Tax Liability for 18 years, with the latest figure at $96.4 million in Q2 2026.
- On a quarterly basis, Non-Current Deferred Tax Liability fell 2.72% year-over-year to $96.4 million in Q2 2026; TTM through Apr 2026 was $96.4 million, a 2.72% decrease from a year earlier, with the FY2025 full-year figure at $93.3 million, down 69.76% from the prior year.
- Non-Current Deferred Tax Liability was $96.4 million for Q2 2026 at Cooper Companies, roughly flat from $96.3 million in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $308.5 million in Q4 2024, with the low at $90.4 million in Q1 2024.
- Average Non-Current Deferred Tax Liability over 5 years is $141.2 million, with a median of $101.2 million recorded in 2022.
- The sharpest annual moves came in 2022 and 2025: Non-Current Deferred Tax Liability soared 490.13% in 2022, then slumped 69.76% in 2025.
- Over 5 years, Non-Current Deferred Tax Liability stood at $287.8 million in 2022, then dropped by 0.59% to $286.1 million in 2023, then advanced by 7.83% to $308.5 million in 2024, then plunged by 69.76% to $93.3 million in 2025, then rose by 3.32% to $96.4 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $96.4 million (Q2 2026), $96.3 million (Q1 2026), and $93.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn |
| 10 | Cooper Companies | 10.51 Bn | 10.37 Bn | 735.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 96.40 Mn |
| Jan 31, 2026 | 96.30 Mn |
| Oct 31, 2025 | 93.30 Mn |
| Jul 31, 2025 | 101.80 Mn |
| Apr 30, 2025 | 99.10 Mn |
| Jan 31, 2025 | 95.20 Mn |
| Oct 31, 2024 | 308.50 Mn |
| Jul 31, 2024 | 94.90 Mn |
| Apr 30, 2024 | 94.20 Mn |
| Jan 31, 2024 | 90.40 Mn |
| Oct 31, 2023 | 286.10 Mn |
| Jul 31, 2023 | 137.60 Mn |
| Apr 30, 2023 | 139.00 Mn |
| Jan 31, 2023 | 144.30 Mn |
| Oct 31, 2022 | 287.80 Mn |
| Jul 31, 2022 | 143.80 Mn |
| Apr 30, 2022 | 131.60 Mn |
| Jan 31, 2022 | 100.60 Mn |
| Oct 31, 2021 | 113.00 Mn |
| Jul 31, 2021 | 28.80 Mn |